Suchergebnisse - "de Sousa, Eric"

PubPharm (8)

1

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

enthalten in: bioRxiv.org | 2024

von Fahrner, J. | Carrier, A. | De Sousa, E. | +52

2

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

enthalten in: Oncoimmunology | 2023

von Bigenwald, C. | Haddad, Y. | Thelemaque, C. | +17

3

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

enthalten in: Cancer discovery | 2022

von Fahrner, J. | Lahmar, I. | Goubet, A. | +65

CommentIn: Cancer Discov. 2022 Apr 1;12(4):892-894. - PMID 35373282

4

Targeting Neoepitopes to Treat Solid Malignancies : Immunosurgery

enthalten in: Frontiers in immunology | 2021

von de Sousa, E. | Lérias, J. | Beltran, A. | +11

5

Mortality in COVID-19 disease patients : Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von de Sousa, E. | Ligeiro, D. | Lérias, J. | +9

6

Clinically Relevant Immune Responses against Cytomegalovirus : Implications for Precision Medicine

enthalten in: International journal of molecular sciences | 2019

von Lérias, J. | Paraschoudi, G. | Silva, I. | +9

7

Trained Immunity for Personalized Cancer Immunotherapy : Current Knowledge and Future Opportunities

enthalten in: Frontiers in microbiology | 2019

von Lérias, J. | de Sousa, E. | Paraschoudi, G. | +12

8

Microbes as Master Immunomodulators : Immunopathology, Cancer and Personalized Immunotherapies

enthalten in: Frontiers in cell and developmental biology | 2019

von Lérias, J. | Paraschoudi, G. | de Sousa, E. | +11

1
[1]